Wikidata

(Q63397805)

English

A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

clinical trial

In more languages

Statements

short name
AD Up (English)
0 references
title
A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Subjects With Moderate to Severe Atopic Dermatitis (English)
0 references
medical condition
dermatitis
0 references
eczema
0 references
sponsor
AbbVie
0 references
country
Australia
0 references
Austria
0 references
Belgium
0 references
Canada
0 references
France
0 references
Germany
0 references
Greece
0 references
Hungary
0 references
Republic of Ireland
0 references
Israel
0 references
Italy
0 references
Japan
0 references
Netherlands
0 references
New Zealand
0 references
Norway
0 references
Slovakia
0 references
Spain
0 references
Sweden
0 references
United Kingdom
0 references
start time
9 August 2018
0 references
end time
20 December 2019
0 references
number of participants
810
0 references
minimum age
12 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63397805&oldid=1857203760"